arginine has been researched along with salmeterol xinafoate in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Aziz, I; Lipworth, BJ | 1 |
Ismail, T; Lee, S; Lipworth, BJ; Macgregor, DF; Mukhopadhyay, S; Palmer, CN | 1 |
Taylor, DR | 1 |
Anderson, WH; Edwards, LD; Klotsman, M; Ortega, HG; Yancey, SW | 1 |
Anderson, WH; Bleecker, ER; Corren, J; Emmett, AH; Kraft, M; Meyers, DA; Nelson, HS; Ortega, HG; Yancey, SW | 1 |
Bateman, ED; Engel, M; Fabbri, LM; Kornmann, O; Pivovarova, A; Schmidt, P | 1 |
Basu, K; Donald, HP; Lipworth, BJ; Macgregor, DF; Mukhopadhyay, S; Ogston, SA; Palmer, CN; Tavendale, R | 1 |
Andrews, H; Canfield, S; DiMango, E; Lederer, D; Mansukhani, M; McGoey, B; Michelis, MA; Paige, A; Slankard, M | 1 |
1 review(s) available for arginine and salmeterol xinafoate
Article | Year |
---|---|
beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Arginine; Asthma; Genotype; Humans; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate | 2007 |
5 trial(s) available for arginine and salmeterol xinafoate
Article | Year |
---|---|
In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Arginine; Bronchi; Bronchial Provocation Tests; Bronchodilator Agents; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Genotype; Glutamic Acid; Glutamine; Glycine; Homozygote; Humans; Male; Methacholine Chloride; Middle Aged; Muscle Contraction; Polymorphism, Genetic; Salmeterol Xinafoate; Spirometry | 1999 |
Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; Arginine; Asthma; Bronchodilator Agents; Child; Female; Fluticasone; Glycine; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Prospective Studies; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Young Adult | 2010 |
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
Topics: Administration, Inhalation; Albuterol; Arginine; Asthma; Bronchodilator Agents; Double-Blind Method; Female; Genotype; Humans; Male; Peak Expiratory Flow Rate; Polymorphism, Single Nucleotide; Receptors, Adrenergic, beta-2; Respiratory Function Tests; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome | 2011 |
Tailored second-line therapy in asthmatic children with the Arg(16) genotype.
Topics: Acetates; Adolescent; Adrenergic beta-2 Receptor Agonists; Albuterol; Amino Acid Motifs; Anti-Asthmatic Agents; Arginine; Asthma; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Humans; Male; Polymorphism, Genetic; Quinolines; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Sulfides | 2013 |
Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Alleles; Anti-Asthmatic Agents; Arginine; Asthma; Double-Blind Method; Female; Fluticasone; Glycine; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Treatment Outcome | 2016 |
3 other study(ies) available for arginine and salmeterol xinafoate
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol.
Topics: Adolescent; Adrenergic beta-Agonists; Albuterol; Arginine; Asthma; Child; Cross-Sectional Studies; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Scotland | 2006 |
Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Amino Acid Substitution; Androstadienes; Arginine; Asthma; Bronchodilator Agents; DNA; DNA Primers; Female; Fluticasone; Genotype; Glycine; Humans; Male; Middle Aged; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Respiratory Function Tests; Retrospective Studies; Salmeterol Xinafoate; Young Adult | 2009 |